Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer

INTRODUCTION: Adjuvant endocrine therapy induces bone loss and increases fracture risk in women with hormone-receptor positive, early-stage breast cancer (EBC). We aimed to update a previous position statement on the management of aromatase inhibitors (AIs) induced bone loss and now included premeno...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Bone Oncol
Autors principals: Waqas, Komal, Lima Ferreira, Joana, Tsourdi, Elena, Body, Jean-Jacques, Hadji, Peyman, Zillikens, M.C.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8080519/
https://ncbi.nlm.nih.gov/pubmed/33948427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2021.100355
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars